Gabelli Healthcare & WellnessRx Trust (GRX) holder Saba Capital adds to stake

Rhea-AI Filing Summary

Saba Capital Management, L.P., a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported a purchase of common stock. On 2026-08-14 it bought 1,203 shares at $9.86 per share in an open market or private transaction, bringing its reported indirect holdings to 2,119,604 shares.

Insider Trade Summary

Net Buyer: 1,203 shares

Net Buy 1 txn

Insider Saba Capital Management, L.P.

Role 10% Owner

Bought 1,203 shs ($12K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,203	$9.86	$12K

Holdings After Transaction: Common Stock — 2,119,604 shares (Indirect, -)

Key Figures

Shares purchased: 1,203 shares Purchase price: $9.86 per share Total shares after transaction: 2,119,604 shares +1 more

4 metrics

Shares purchased 1,203 shares Common Stock transaction on 2026-08-14

Purchase price $9.86 per share Price for the 1,203-share Common Stock purchase

Total shares after transaction 2,119,604 shares Indirect Common Stock holdings following the reported purchase

Net buy shares 1,203 shares Net buy direction across all reported transactions in this filing

Key Terms

ten percent owner, indirect, Purchase in open market or private transaction

3 terms

ten percent owner regulatory

"the reporting person is marked as a ten percent owner of the issuer"

indirect financial

"the ownership type for the reported Common Stock holdings is classified as indirect"

Purchase in open market or private transaction financial

"the transaction code description states Purchase in open market or private transaction"

FAQ

What insider transaction did GRX holder Saba Capital Management report on this Form 4?

Saba Capital Management reported buying 1,203 GRX common shares on 2026-08-14. The shares were purchased in an open market or private transaction at a reported price of $9.86 per share.

How many GRX shares does Saba Capital Management hold after the reported transaction?

After the transaction, Saba Capital Management is reported to hold 2,119,604 GRX shares indirectly. This figure reflects the total common stock position following the 1,203-share purchase disclosed in the Form 4.

Was the GRX insider trade by Saba Capital a purchase or a sale?

The reported GRX insider trade was a purchase. Saba Capital Management acquired 1,203 common shares on 2026-08-14, coded as a “P” transaction, indicating a purchase in an open market or private transaction.

At what price did Saba Capital Management buy GRX shares in this Form 4?

Saba Capital Management bought the GRX common shares at a reported $9.86 per share. The Form 4 notes this price as a per-share transaction price for the 1,203 shares purchased on 2026-08-14.

Is Saba Capital Management a ten percent owner of GRX in this filing?

Yes, Saba Capital Management is identified as a ten percent owner of GRX. The reporting-person information marks the firm with ten percent owner status and not as a director or officer of Gabelli Healthcare & WellnessRx Trust.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/17/2026 - 10:40 AM Accepted by SEC EDGAR 08/17/2026 - 10:39 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Saba Capital Management, L.P.

(Last) (First) (Middle)

405 LEXINGTON AVENUE

58TH FLOOR

(Street)

NEW YORK NEW YORK 10174

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Gabelli Healthcare & WellnessRx Trust [ GRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/14/2026		P		1,203	A	$9.86	2,119,604	I	-

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Saba Capital Management, L.P. By: Zachary Gindes	08/17/2026
	Boaz Weinstein	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)